ALK-Abelló A/S
ALK-Abelló A/S is a Denmark-based company in the Healthcare sector with a market capitalisation of $6.8B. Its FinScore is 69/100; its highest-scoring layer is Quality (76) and its lowest is Value (51). The shares trade at 33.4x trailing earnings and are down 7% year to date.
Share price performance
About ALK-Abelló A/S
www.alk.netEstablished in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allergy solutions to markets across Europe, North America, and other international regions. These offerings include immunotherapy products delivered through injections, sublingual drops, and oral tablets, designed to address various allergies such as those caused by house dust mites, grass, tree, ragweed, and Japanese cedar. ALK-Abelló also manufactures adrenaline auto-injectors for the critical management of severe allergic reactions and produces diagnostic tools essential for identifying allergic conditions. Their product portfolio features notable treatments like GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX, all aimed at allergic rhinitis, as well as ACARIZAX, which targets both allergic rhinitis and allergic asthma.
- Sector
- Healthcare
- Industry
- Biotechnology
- HQ
- Denmark
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- DKK
- Fundamentals updated
- 6 days ago
- Market cap
- $6.8B
- Shares outstanding
- 201.6M
- P/E (TTM)
- 33.4x
- Dividend yield (TTM)
- 0.72%
- Beta (issuer)
- 0.71
- Revenue (latest FY)
- DKK 6.3B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for ALK-Abelló A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.